| Case Western Reserve University School of Medicine | ||
| City: Cleveland | State: OH | |
|
Links:
Commentary:2009_06_19_Approved_Case_COI_Policies_with_Document_History.pdf 2010_11_23_CWRUOutsideInterestForm-_Staff__Advisee_Notification.dot 2010_20CWRU_20Procurement_20Policy.pdf 2010_11_30_2010_Case_FI_Report_all_screens_1_.pdf CWRU_SOM_T35Training.docx CWRU-CME_ReportForm.pdf CWRUsponsoredresearch_guidelines.pdf Tuesday_Seminars_COI_session_1_.doc Summary: Case Western Reserve University School of Medicine submitted new policies in 2011-12 which did not alter scores in any domain. At Case, there is a limited scope of seemingly good policies, due to multiple policies at different affiliate sites which are not unified. The aggregate scores were lower than some of the individual hospital policies. To be specific, with gifts, multiple policies were similar prohibitive. However, samples were prohibited in one policy but not the other. The curriculum goes beyond the scope of just the institution's policy and addresses pharmaceutical marketing, financial conflicts of interest, and its effects on physician decision-making. Demographics: The three primary sites of student training are University Hospitals Case Medical Center which includes an affiliated Veterans Affairs hospital, the Cleveland Clinic, and MetroHealth Medical Center. Training is split roughly 33% at each hospital. Policies were submitted from the school of medicine and each affiliate hospital. Updates: This institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard. This institution's evaluation was last updated: 2/28/2012. |
||
| Gifts & Meals | ![]() |
Neither food, beverage or anything of value may be received by employees or trainers, except as modest meals provided at off-site events. |
| Consulting relationships | ![]() |
Not all consulting relationships require formal contracts, some require writing by letter or by a written agreement. Payments must be of fair market value. |
| Industry-funded speaking relationships | ![]() |
Speakers must have control over content. Pre-approval is required for presenting lectures where payment is given directly or indirectly by Pharm industry |
| Disclosure | ![]() |
All employees are required to disclose all financial conflicts. |
| Pharmaceutical samples | ![]() |
The academic medical center submitted policies from multiple affiliate hospitals which differ, half of covered faculty are prohibited from receiving samples. |
| Purchasing & Formularies | ![]() |
Individuals with financial interests are required to recuse themselves from business decisions. |
| Industry Sales Representatives | ![]() |
Industry sales representatives are permitted only by faculty appointment. |
| On-campus Education | ![]() |
Conflicts associated with CME events are reviewed by Activity Director, Director/Medical Director/Chairman of CME committee. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | ![]() |
Defraying of travel costs by industry is not permitted for employees of one affiliate. There is no such policy in the other affiliate hospital's COI document. |
| Industry Support for Scholarships & Funds for Trainees | ![]() |
No policy available. |
| Medical school curriculum | ![]() |
The curricular objectives adequately address pharmaceutical marketing, financial COI, and its effects on physician decision-making and health care. The curriculum goes beyond the scope of just the institution's policy |
| Do the policies specify an oversight mechanism? | ![]() |
Oversight is clearly stated. |
| Are there explicit sanctions for noncompliance? | ![]() |
Sanctions for non-compliance are outlined depending on degree/nature of offense. |
| Model policy | |
| Good progress toward model policy | |
| No policy, or policy unlikely to have a substantial effect on behavior | |
| Did not report | |
| Policy not relevant to this institution (e.g., does not make purchasing decisions) | |